Answers are grounded in this paper and cite their sources.
GSTP1 promoter DNA methylation is an established epigenetic biomarker for early prostate cancer diagnosis. Here, a WS2−AuNP heterostructure-based bio-field-effect transistor (Bio-FET) is developed for rapid, MSRE-assisted, label-free electrical detection of GSTP1 methylation-associated DNA targets, following methylation-dependent restriction digestion of genomic DNA. The device integrates a two-dimensional WS2 transduction channel with an AuNP-conjugated thiolated DNA probe to enable sequence-specific recognition of GSTP1 target DNA through an MSRE-assisted detection strategy. Specifically, HpaII/MspI-mediated restriction processing introduces methylation-dependent discrimination, while subsequent DNA purification, denaturation and sequence-specific probe hybridization enable electrical detection of the retained GSTP1 target sequences. The electrical responses obtained using LNCaP and WI-38 genomic DNA, together with complementary and non-complementary target controls, demonstrate the feasibility of the proposed approach for methylation-associated GSTP1 detection. The AuNPs provide a surface for thiolated-probe immobilization through Au−S interactions, while their independent contribution to sensing performance remains to be established through comparative device studies. Structural and electrical characterization by SEM, Raman spectroscopy, UV−visible spectroscopy, and field-effect transistor measurements verified successful heterostructure fabrication, stable biofunctionalization, and selective target recognition. By avoiding bisulfite conversion, the MSRE-assisted workflow simplifies epigenetic analysis while enabling label-free electrical detection of the processed GSTP1 targets. The sensing range, rapid real-time response, and label-free operation highlight the potential of this platform for future development toward minimally invasive molecular diagnostic and point-of-care sensing. These results demonstrate the potential of WS2−AuNP heterostructures as nano-biointerfaces for ultrasensitive bioelectronic sensing and minimally invasive epigenetic diagnostics.
No takes yet. Share an insight, caveat, or question.
Kar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: